Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery

Anesthesia and Analgesia

Volumn 99, Issue 5, 2004, Pages 1465-1471

  Lu, Chueng He ^a   Chao, Pei Chieh ^a   Borel, Cecil O ^b   Yang, Chih Ping ^a   Yeh, Chun Chang ^a   Wong, Chih Shung ^a   Wu, Ching Tang ^a  

^a NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; ATROPINE; CYTOKINE; DESFLURANE; EDROPHONIUM; FENTANYL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIDOCAINE; MORPHINE; PENTOXIFYLLINE; PROCHLORPERAZINE; THIOPENTAL; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANESTHESIA INDUCTION; ANESTHESIA MECHANISM; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLON SURGERY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DIZZINESS; DROWSINESS; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; HYPERALGESIA; INTESTINE FUNCTION; MALE; METASTASIS; NAUSEA; OPIOID INDUCED EMESIS; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM SURGERY; SIDE EFFECT; SKIN INCISION; TUMOR RECURRENCE; VENOUS BLOOD; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; ANESTHESIA, GENERAL; COLORECTAL NEOPLASMS; CYTOKINES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTESTINES; MALE; MIDDLE AGED; MORPHINE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS;

EID: 6444220117     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000132974.32249.C8     Document Type: Article

References (26)

1. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995;63:289-302.
2. Beilin B, Shavit Y, Trabekin E, et al. The effects of postoperative pain management on immune response to surgery. Anesth Analg 2003;97:822-7.
3. Page GG. The immune-suppressive effects of pain. Adv Exp Med Biol 2003;521:117-25.
4. Watkins LR, Milligan ED, Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 2003;521:1-21.
5. Wordliczek J, Szczepanik AM, Banach M, et al. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci 2000;66:1155-64.
6. Cruickshank AM, Fraser WD, Burns HJ, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 1990;79:161-5.
7. Schneider H, Pitossi F, Balschun D, et al. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci U S A 1998;95:7778-83.
8. Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol 2000;130:1418-24.
9. Kalff JC, Turler A, Schwarz NT, et al. Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy. Ann Surg 2003;237:301-15.
10. Holzheimer RG, Steinmetz W. Local and systemic concentrations of pro- and anti-inflammatory cytokines in human wounds. Eur J Med Res 2000;5:347-55.
11. Naito Y, Tamai S, Shingu K, et al. Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 1992;77:426-31.
12. Koo DJ, Yoo P, Cioffi WG, et al. Mechanism of the beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines. J Surg Res 2000;91:70-6.
13. Josephs MD, Solorzano CC, Taylor M, et al. Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra. Am J Physiol Regul Integr Comp Physiol 2000;278:R824-30.
14. Wu FP, Sietses C, von Blomberg BM, et al. Systemic and peritoneal inflammatory response after laparoscopic or conventional colon resection in cancer patients: a prospective, randomized trial. Dis Colon Rectum 2003;46:147-55.
15. Sachs D, Cunha FQ, Poole S, Ferreira SH. Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain 2002;96:89-97.
16. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 1991;104:765-7.
17. Josaki K, Contrino J, Kristie J, et al. Pentoxifylline-induced modulation of human leukocyte function in vitro. Am J Pathol 1990;136:623-30.
18. Matsushima K, Morishita K, Yoshimura T, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by Interleukin-1 and tumor necrosis factor. J Exp Med 1988;167:1883-93.
19. Fischer E, Van Zee KJ, Marano MA, et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992;79:2196-200.
20. Ishihara Y, Nishihara T, Kuroyanagi T, et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 1997;32:524-9.
21. Arend WP, Evans CH. Interleukin-1 receptor antagonist [IL-1F3]. In: Thomson AW, Lotze MT, eds. The cytokine handbook. 4th ed. London: Elsevier Science, 2003:669-708.
22. Gotoh M, Hamada K, Yamakawa H, et al. Interleukin-1-induced subacromial synovitis and shoulder pain in rotator cuff diseases. Rheumatology 2001;40:995-1001.
23. Schubert P, Ogata T, Marchini C, et al. Protective mechanisms of adenosine in neurons and glial cells. Ann N Y Acad Sci 1997;825:1-10.
24. Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003;63:649-71.
25. Hadjiminas DJ, McMasters KM, Robertson SE, Cheadle WG. Enhanced survival from cecal ligation and puncture with pentoxifylline is associated with altered neutrophil trafficking and reduced interleukin-1 beta expression but not inhibition of tumor necrosis factor synthesis. Surgery 1994;116:348-55.
26. Nelson JL, Alexander JW, Mao JX, et al. Effect of pentoxifylline on survival and intestinal cytokine messenger RNA transcription in a rat model of ongoing peritoneal sepsis. Crit Care Med 1999;27:113-9.